Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.

Oncotarget - 22 Sept 2015

Bi Chonglei, Chung Tae-Hoon, Huang Gaofeng, Zhou Jianbiao, Yan Junli, Ahmann Gregory J, Fonseca Rafael, Chng Wee Joo

Abstract excerpt

Epigenetic alterations have emerged as an important cause of microRNA (miRNA) deregulation. In Multiple Myeloma (MM), a few tumor suppressive miRNAs silenced by DNA hypermethylation have been reported, but so far there are few systemic investigations on epigenetically silenced miRNAs. We conducte...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Movement
Share to DNA Modification Methylases
Share to Enzyme Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Silencing

Share to MicroRNAs

Share to Multiple Myeloma

Share to Oligonucleotide Array Sequence Analysis

Share to Proportional Hazards Models

Source

Open in PubMed Open full text

Identifiers

PMID: 26164366
DOI: 10.18632/oncotarget.4769
PMCID: PMC4694918

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-26164366-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.PMID 26164366Read ↗

MiRNA as a Potential Target for Multiple Myeloma Therapy–Current Knowledge and PerspectivesSemantic proximity Read ↗

Role of epigenetics-microRNA axis in drug resistance of multiple myelomaSemantic proximity Read ↗

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesisSemantic proximity Read ↗

MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow MicroenvironmentSemantic proximity Read ↗

The potential role of miRNAs in multiple myeloma therapySemantic proximity Read ↗

Roles of miRNA dysregulation in the pathogenesis of multiple myelomaSemantic proximity Read ↗

Aberrant micro<scp>RNA</scp> expression in multiple myelomaSemantic proximity Read ↗

MicroRNA and Multiple Myeloma: from Laboratory Findings to Translational Therapeutic ApproachesSemantic proximity Read ↗

The Role and Function of microRNA in the Pathogenesis of Multiple MyelomaSemantic proximity Read ↗

Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impactSemantic proximity Read ↗

The Multiple Myeloma Landscape: Epigenetics and Non-Coding RNAsSemantic proximity Read ↗

MicroRNAs in multiple myeloma and related bone disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.